Novo Nordisk Aktie
65,38
EUR
-1,91
EUR
-2,84
%
61,55
CHF
-2,32
CHF
-3,63
%
Werbung
Novo Nordisk Aktie Analyse
24.03.25 | Novo Nordisk Buy | Deutsche Bank AG | |
21.03.25 | Novo Nordisk Buy | UBS AG | |
17.03.25 | Novo Nordisk Buy | UBS AG | |
14.03.25 | Novo Nordisk Buy | UBS AG | |
11.03.25 | Novo Nordisk Buy | Deutsche Bank AG | |
11.03.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
10.03.25 | Novo Nordisk Buy | UBS AG | |
10.03.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
Werbung
|
|||
07.03.25 | Novo Nordisk Buy | UBS AG | |
04.03.25 | Novo Nordisk Buy | Deutsche Bank AG | |
03.03.25 | Novo Nordisk Buy | UBS AG | |
26.02.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
24.02.25 | Novo Nordisk Buy | UBS AG | |
19.02.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
17.02.25 | Novo Nordisk Buy | UBS AG | |
17.02.25 | Novo Nordisk Buy | Deutsche Bank AG | |
12.02.25 | Novo Nordisk Buy | Deutsche Bank AG | |
11.02.25 | Novo Nordisk Buy | Deutsche Bank AG | |
10.02.25 | Novo Nordisk Buy | UBS AG | |
10.02.25 | Novo Nordisk Buy | Deutsche Bank AG | |
10.02.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
07.02.25 | Novo Nordisk Buy | UBS AG | |
06.02.25 | Novo Nordisk Buy | Deutsche Bank AG | |
06.02.25 | Novo Nordisk Buy | UBS AG | |
06.02.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
05.02.25 | Novo Nordisk Buy | UBS AG | |
05.02.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
05.02.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
03.02.25 | Novo Nordisk Buy | UBS AG | |
29.01.25 | Novo Nordisk Buy | UBS AG | |
29.01.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
28.01.25 | Novo Nordisk Buy | UBS AG | |
27.01.25 | Novo Nordisk Buy | Deutsche Bank AG | |
24.01.25 | Novo Nordisk Buy | UBS AG | |
24.01.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
24.01.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
21.01.25 | Novo Nordisk Buy | UBS AG | |
17.01.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
17.01.25 | Novo Nordisk Buy | UBS AG | |
16.01.25 | Novo Nordisk Buy | UBS AG | |
13.01.25 | Novo Nordisk Buy | UBS AG | |
10.01.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
10.01.25 | Novo Nordisk Buy | Deutsche Bank AG | |
08.01.25 | Novo Nordisk Buy | UBS AG | |
06.01.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
06.01.25 | Novo Nordisk Buy | Deutsche Bank AG | |
23.12.24 | Novo Nordisk Overweight | Barclays Capital | |
17.12.24 | Novo Nordisk Buy | Deutsche Bank AG | |
16.12.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
12.12.24 | Novo Nordisk Buy | Deutsche Bank AG |
Werbung
Werbung